James Karis Teams With Tegal's Thomas Mika as Co-CEO of Tegal Corporation

Tegal Corporation

today announced that it expects to appoint James Karis as Co-CEO of Tegal Corporation. The appointment will be effective upon completion of Tegal's pending acquisition of CollabRx, Inc, where Mr. Karis currently serves as CEO and a director. Mr. Karis will join Tegal's Chairman, President and current CEO Thomas Mika in the Co-CEO role. Tegal announced earlier today that it has signed a definitive agreement to acquire CollabRx, Inc., a privately held technology company in the rapidly growing market of interpretive content and data analytics for genomics-based medicine. The combined, publicly traded company intends to operate under the CollabRx name and will locate its headquarters in San Francisco, CA. Upon completion of the pending transaction, Mr. Karis also will be appointed to Tegal's Board of Directors.